Table 1.
Patient characteristics on enrollment.
| Characteristic | Value |
|---|---|
| N | 191 |
| Female | 49·2% (94/191) |
| Median age (IQR) | 47 (IQR 34 – 61) |
| Medical history: | |
| Lung disease | 12·6% (24/191) |
| Cancer | 13·6% (26/191) |
| Diabetes | 26·7% (51/191) |
| Immunosuppression | 7·3% (14/191) |
| Heart disease | 11·0% (21/191) |
| Hypertension | 36·6% (70/191) |
| ACE/ARB use | 18·3% (35/191) |
| Stroke | 4·2% (8/191) |
| De mentia | 4·7% (9/191) |
| DVT/PE | 5·8% (11/191) |
| Chronic kidney disease | 9·9% (19/191) |
| Smoking | 20·9% (40/191) |
| Symptoms on presentation: | |
| Fever | 64·4% (123/191) |
| Chills | 31·4% (60/191) |
| Cough | 67·5% (129/191) |
| Sore throat | 16·2% (31/191) |
| Congestion | 8·4% (16/191) |
| Shortness of breath | 63·4% (121/191) |
| Chest pain | 34·6% (66/191) |
| Myalgia | 34·6% (66/191) |
| Nausea/vomiting/diarrhea | 40·8% (78/191) |
| Loss of taste | 38·7% (74/191) |
| Loss of smell | 27·2% (52/191) |
| Confusion | 2·6% (5/191) |
| Headache | 26·2% (50/191) |
ACE = Angiotensin-converting enzyme inhibitor, ARB = Angiotensin receptor blocker, DVT = deep vein thrombosis, PE = pulmonary embolus.